Latest news

Ophthalmologist to reveal more about new drug for two types of macular disease

Posted: Wednesday 3 August 2022 at 14:13

An ophthalmologist who has worked on the clinical trials for the latest drug approved to treat wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO) will reveal more about the treatment and how you can access it.

Find out more

"It could be life-changing for so many people"

Posted: Wednesday 3 August 2022 at 13:44

A 75-year-old man involved in a clinical trial for a new implant for wet age-related macular degeneration (AMD) says it would be ‘magic’ if the trial is successful.

Find out more

New National Clinical Director for Eye Care appointed

Posted: Monday 1 August 2022 at 15:05

A new role which could help transform eye care services for people living with macular disease and other sight conditions, has been appointed by NHS England.

Find out more

New treatment option approved for patients with diabetic macular oedema

Posted: Thursday 28 July 2022 at 09:00

Patients living with diabetes-related sight loss could be treated with a new drug, following a recommendation from The National Institute for Health and Care Excellence (NICE).

Find out more

Cheaper drugs for wet AMD becoming available on the NHS

Posted: Tuesday 19 July 2022 at 13:44

New forms of anti-VEGF drugs will soon be available to treat wet age-related macular degeneration (AMD) thanks to the production of biosimilars.

Find out more

Double donations for Amazon Prime Day

Posted: Thursday 7 July 2022 at 11:21

The Macular Society will benefit from double donations on eligible purchases made by Amazon Prime members later this month, helping us to raise vital funds for macular research.

Find out more

Eat for your eyes - how food is important for our sight

Posted: Wednesday 6 July 2022 at 15:13

What are the best foods to eat to look after your eyes?

Find out more

Research Bunson Burner

Gene editing to treat inherited macular disease

Posted: Tuesday 5 July 2022 at 08:52

A research team is making strides in using gene-editing techniques to treat a rare, inherited form of macular disease.

Find out more